Updated Date: Tue, 14 Feb 2023 00:00:00 EST

Boost for effected patients as HEMGENIX receives green light from European Commission

Final draft guidance from NICE ensures people at highest risk will have access to COVID-19 therapies

Updated Date: Mon, 13 Feb 2023 00:00:00 EST

Updated Date: Mon, 13 Feb 2023 00:00:00 EST

Updated Date: Mon, 13 Feb 2023 00:00:00 EST

Updated Date: Mon, 13 Feb 2023 00:00:00 EST

Updated Date: Mon, 13 Feb 2023 00:00:00 EST

VLA1553 is a single-dose, live-attenuated vaccine candidate targeting the highly dangerous chikungunya virus

Research concerns the effect of niraparib when combined with abiraterone acetate plus prednisone